Active Surveillance for Patients with Low-Risk Localized Prostate Cancer

Abstract

Sponsoring Organization: American Society of Clinical Oncology (ASCO) Target Audience: Oncologists, urologists, primary care physicians Background Active surveillance (AS) is used increasingly as an alternative to immediate treatment (e.g., radical prostatectomy, radiation therapy) for patients with low-risk localized prostate cancer. Recently, Cancer Care Ontario published a guideline entitled “Active Surveillance for the Management of Localized Prostate Cancer” (Can Urol Assoc J 2015; 9:171). ASCO now has formally endorsed most recommendations in that guideline. Key Recommendations